Literature DB >> 16730676

Cerebral ischemia induces neuronal expression of novel VL30 mouse retrotransposons bound to polyribosomes.

Willard J Costain1, Ingrid Rasquinha, Tyson Graber, Christian Luebbert, Edward Preston, Jacqueline Slinn, Xiaoqi Xie, John P MacManus.   

Abstract

Mammalian genomes are burdened with a large heterogeneous group of endogenous replication defective retroviruses (retrotransposons). Previously, we identified a transcript resembling a virus-like 30S (VL30) retrotransposon increasing in mouse brain following transient cerebral ischemia. Paradoxically, this non-coding RNA was found bound to polyribosomes. Further analysis revealed that multiple retrotransposon species (BVL-1-like and mVL30-1-like) were bound to polyribosomes and induced by ischemia. These VL30 transcripts remained associated with polyribosomes in the presence of 0.5 M KCl, indicating that VL30 mRNA was tightly associated with ribosomal subunits. Furthermore, the profile of BVL-1 distribution on polyribosomal profiles was distinct from those of translated and translationally repressed mRNA. Consistent with expectations, 5.0 kb VL30 transcripts were detected in ischemic brain with a temporal pattern of expression that was distinct from c-fos. Expression of VL30 was localized in neurons using a combination of in situ hybridization and immunocytochemistry. 3'-RACE-PCR experiments yielded two unique sequences (VL30x-1 and VL30x-2) that were homologous to known VL30 genes. Phylogenetic analysis of VL30 promoter sequence (U3 region) resulted in the identification of two large VL30 subgroups. VL30x-1 and VL30x-2 were closely related and classified in a group that was distinct from the well-characterized VL30 genes BVL-1 and mVL30-1. The promoter regions of VL30x-1 and VL30x-2 did not possess the consensus sequences for either hypoxia or anoxia response elements, suggesting an alternative mechanism for induction. This is the first report that demonstrates ischemia-induced, neuronal expression of unique VL30 retrotransposons in mouse brain.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16730676     DOI: 10.1016/j.brainres.2006.03.120

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  6 in total

Review 1.  Synergy of homocysteine, microRNA, and epigenetics: a novel therapeutic approach for stroke.

Authors:  Anuradha Kalani; Pradeep K Kamat; Suresh C Tyagi; Neetu Tyagi
Journal:  Mol Neurobiol       Date:  2013-02-22       Impact factor: 5.590

Review 2.  Molecular regulation of cell fate in cerebral ischemia: role of the inflammasome and connected pathways.

Authors:  George Trendelenburg
Journal:  J Cereb Blood Flow Metab       Date:  2014-09-17       Impact factor: 6.200

Review 3.  The emerging role of epigenetics in stroke: II. RNA regulatory circuitry.

Authors:  Irfan A Qureshi; Mark F Mehler
Journal:  Arch Neurol       Date:  2010-12

4.  Epigenetic regulation of a murine retrotransposon by a dual histone modification mark.

Authors:  Reinhard Brunmeir; Sabine Lagger; Elisabeth Simboeck; Anna Sawicka; Gerda Egger; Astrid Hagelkruys; Yu Zhang; Patrick Matthias; Wolfgang J Miller; Christian Seiser
Journal:  PLoS Genet       Date:  2010-04-29       Impact factor: 5.917

5.  Genomic analysis of mouse VL30 retrotransposons.

Authors:  Georgios Markopoulos; Dimitrios Noutsopoulos; Stefania Mantziou; Demetrios Gerogiannis; Soteroula Thrasyvoulou; Georgios Vartholomatos; Evangelos Kolettas; Theodore Tzavaras
Journal:  Mob DNA       Date:  2016-05-06

6.  VL30 retrotransposition is associated with induced EMT, CSC generation and tumorigenesis in HC11 mouse mammary stem‑like epithelial cells.

Authors:  Soteroula Thrasyvoulou; Georgios Vartholomatos; Georgios Markopoulos; Dimitrios Noutsopoulos; Stefania Mantziou; Foteini Gkartziou; Panagiotis Papageorgis; Antonia Charchanti; Panos Kouklis; Andreas I Constantinou; Theodore Tzavaras
Journal:  Oncol Rep       Date:  2020-04-28       Impact factor: 3.906

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.